Apiscent’s assets, totaling $3.7 million, fall short of its $5.5 million in liabilities, the bank said. For the first four months of 2018, the firm lost $239,000, according to an affidavit by a bank officer.

CIBM said it is owed $1.7 million.

In another court filing, Apiscent admitted that the bank’s allegations are true and did not contest the appointment of a receiver.

A judge named attorney Seth Dizard as receiver with authority to run Apiscent’s business and sell its assets.

Dizard said by email that Apiscent, 4170 S. Nevada Ave., continues to operate and that he is actively seeking buyers in an effort to keep the company afloat.

Apiscent was formed by a group that bought Fontarome Chemical Inc. out of receivership for $2.5 million in 2014.